The 5 tobacco, beer, and distiller/vintner companies with major investments in the cannabis sector, constituents in the munKNEE Conservative “Cannabis” Stocks Portfolio, deserve the “conservative” moniker in the portfolio name given that it has demonstrated its conservative nature this past month of July and month-to-date (MTD) as highlighted below.The constituents in the portfolio are presented below as to their performances MTD (as of the end of Thursday), in descending order, and for the month of July, their ownership in major cannabis stocks, their dividend yields and the latest news, commentary and/or analysis, where available.
Conservative “Cannabis” Stocks Portfolio
- has a 45% stake in Cronos Group (CRON)
- dividend yield: 7.66%
- latest news, commentary and/or analysis:
- Why Is Altria Group, the Best Dividend Aristocrat with Over 3% Yield?
- Is Altria‘s High-Yielding Dividend Still Safe?
- Altria Group Is a Trending Stock: Facts to Know Before Betting on It
- has a $100 million joint venture with Tilray (TLRY)
- dividend yield: 1.44%
- latest news, commentary and/or analysis:
- Why Hedge Funds Are Crazy About Anheuser-Busch InBev
- AB InBev’s “encouraging” first-half – key takeaways
- has a C$346M product development partnership with Organigram Holdings (OGI)
- dividend yield: 8.19%
- latest news, commentary and/or analysis:
- Are Investors Undervaluing British American Tobacco?
- Hedge Funds Are Bullish on British American Tobacco – Here’s Why
- British American Tobacco First Half 2024 Earnings: EPS Beats Expectations
- has a 19.9% stake in Auxly Cannabis Group (CBWTF)
- dividend yield: 6.76%
- latest news, commentary and/or analysis:
- Should Value Investors Buy Imperial Brands Stock?
- has a 39% stake in Canopy Growth (CGC)
- dividend yield: 1.68%
- latest news, commentary and/or analysis:
- Constellation Brands Is the Best Spirits Stock to Buy Now-Here’s Why
-
Constellation Brands distances itself from cannabis company Canopy Growth
- Constellation intends to convert its stake in Canopy to a new category of shares that do not give voting power or the ability to collect payments from the company and will no longer have representation on Canopy’s board to eliminate the impact to their equity in earnings and do not intend to deploy additional investment in Canopy going forward.
Summary
The munKNEE Conservative “Cannabis” Stocks Portfolio is UP 0.8% MTD, was DOWN 0.1% in July last week, and is UP 5.3% YTD. In addition, the stocks in the Index have an average dividend yield of 3.24% for a gross return of 8.5%.More By This Author:Psychedelic Compound-Based Drug Stocks Portfolio: Up 17.5% In July; Down 19% MTD
Cannabis Company, Organigram, Reports An Impressive Q3 Turnaround
AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD
